We have characterized a diverse range of established canine cancer cell lines, including REM134 mammary carcinoma, D17 osteosarcoma, J3T glioma, SB haemangiosarcoma, 3132 B-cell Non-Hodgkins lymphoma, and have determined that expression of CD44 in canine cancer cells is cell cycle dependent (data unpublished) and is therefore not representative of a CSC marker in this species. The gene discussed is CD44; the disease is B-cell non-Hodgkin lymphoma.